T1	Participants 59 115	premenstrual symptoms with and without ongoing dysphoria
T2	Participants 223 250	premenstrual syndrome (PMS)
T3	Participants 363 544	in a clearly defined PMS sample versus women with premenstrual symptoms in combination with dysphoric symptoms throughout the cycle, termed the premenstrual exacerbation (PME) group
T4	Participants 735 762	Thirty-three eligible women
T5	Participants 1795 1832	women with ongoing dysphoric symptoms
